Clinical Study to Evaluate the Safety, Pharmacokinetics and Efficacy of VC005 in Adolescent Subjects With Mild to Moderate Atopic Dermatitis
Latest Information Update: 15 Jan 2026
At a glance
- Drugs VC 005 (Primary)
- Indications Atopic dermatitis
- Focus Pharmacokinetics
- Sponsors Jiangsu Vcare Pharmatech
Most Recent Events
- 15 Jan 2026 New trial record